Recent Advances in Metal-Based NanoEnhancers for Particle Therapy
Nanomaterials (Basel). 2023 Mar 10;13(6):1011. doi: 10.3390/nano13061011.
YC.Chuang, PH.Wu, YA.Shen, et al.
Polymeric Metal Contrast Agents for T1-Weighted Magnetic Resonance Imaging of the Brain
ACS Biomater Sci Eng. 2023 Mar 13;9(3):1224-1242. doi: 10.1021/acsbiomaterials.2c01386. Epub 2023 Feb 8.
D.Foster, J.Larsen
Prospects of Nanoparticle-based Radioenhancement for Radiotherapy
ChemRxiv. Mar 10. doi: 10.3929/ethz-b-000603237.
L.Gerken, M.Gerdes, M.Pruschy, et al.
Nanomedicine embraces cancer radio-immunotherapy: mechanism, design, recent advances, and clinical translation
Chem Soc Rev. 2023 Jan 3;52(1):47-96. doi: 10.1039/d2cs00437b.
H-Li, Q-Luo, H-Zhang, et al.
Clinical transfer of AGuIX®-based radiation treatments for locally advanced cervical cancer: MR quantification and in vitro insights in the NANOCOL clinical trial framework
Nanomedicine. 2023 Apr 20;50:102676. doi: 10.1016/j.nano.2023.102676. Online ahead of print.
P.Maury, M.Mondini, C.Chargari, et al.
Phase I/II study testing the combination of AGuIX nanoparticles with radiochemotherapy and concomitant temozolomide in patients with newly diagnosed glioblastoma (NANO-GBM trial protocol)
BMC Cancer. 2023 Apr 15;23(1):344. doi: 10.1186/s12885-023-10829-y.
E.Thivat, M.Casile, J.Moreau, et al.